Successful surgical management of infected modified Blalock-Taussig shunts

Cardiology in the Young

Volumn 14, Issue 2, 2004, Pages 219-221

  Ootaki, Yoshio ^a,b   Yamaguchi, Masahiro ^a   Yoshimura, Naoki ^a  

^a KOBE CHILDREN S HOSPITAL   (Japan)

^b NONE   (Japan)

Author keywords

Congenital heart disease; Infection; Prosthetic graft

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER LWOFFII; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BLALOCK TAUSSIG ANASTOMOSIS; CARDIOVASCULAR SURGERY; CASE REPORT; CLINICAL EXAMINATION; CYANOSIS; FALLOT TETRALOGY; FEMALE; FEVER; HEART CATHETERIZATION; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INFANT; LABORATORY TEST; POSTOPERATIVE PERIOD; PROSTHESIS INFECTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; BLOOD VESSEL TRANSPLANTATION; FOLLOW UP; INFECTION; LUNG ATRESIA; MALE; METHODOLOGY; MULTIPLE MALFORMATION SYNDROME; NEWBORN; RADIOGRAPHY; REOPERATION; RISK ASSESSMENT;

ABNORMALITIES, MULTIPLE; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; PROSTHESIS-RELATED INFECTIONS; PULMONARY ATRESIA; REOPERATION; RISK ASSESSMENT; TETRALOGY OF FALLOT; TREATMENT OUTCOME;

EID: 20544468796     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951104002215     Document Type: Article

References (10)

1. Bandyk DF, Novotney ML, Back MR, Johnson BL, Schmacht DC. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 2001; 34: 411-420.
2. Kieffer E, Sabatier J, Plissonnier D, Knosalla C. Prosthetic graft infection after descending thoracic/thoracoabdominal aortic aneurysmectomy: Management with in situ arterial allografts. J Vasc Surg 2001; 33: 671-678.
3. Hayes PD, Nasim A, London NJ, Sayers RD, Barrie WW, Bell PR, Naylor AR. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: The Leicester experience (1992 to 1998). J Vasc Surg 1999; 30: 92-98.
4. Yoshimura N, Yamaguchi M, Ohashi H, Oshima Y, Toyoda Y, Chung HN, Ogawa K. Growth of the subclavian artery and the anastomosis in Blalock-Taussig shunt: Absorbable versus non-absorbable suture. Ann Thorac Surg 1998; 65: 1746-1750.
5. Yoshimura N, Yamaguchi M, Ohashi H, Oshima Y, Toyoda Y, Ogawa K. Classic Blalock-Taussig shunt in neonates. J Cardiovasc Surg (Torino) 1999; 40: 107-110.
6. Juneja R, Kothari SS, Kumar K, Guruprasad G, Wasir HS. Fatal Salmonella typhimurium infection of a vascular graft in an infant. Pediatr Cardiol 1996; 17: 330-331.
7. Turner SW, Wyllie JP, Hamilton JRL, Bain HH. Diagnosis of infected modified Blalock-Taussig shunt by computed tomography. Ann Thorac Surg 1995; 59: 1216-1217.
8. Stone KS, Walshaw R, Sugiyama GT, Dean RE, Dunstan RW. Polytetrafluoroethylene versus autogenous vein grafts for vascular reconstruction in contaminated wounds. Am J Surg 1984; 147: 692-695.
9. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916-2921.
10. Lehnhardt FJ, Torsello G, Claeys LG, Pfeiffer M, Wachol-Drewek Z, Grundmann RT, Sandmann W. Systemic and local antibiotic prophylaxis in the prevention of prosthetic vascular graft infection: An experimental study. Ent J Vasc Endovasc Surg 2002; 23: 127-133.